Why Hexo (TSX:HEXO) Stock Dropped 25% on Thursday and Why it Could Reverse Course Quickly

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) stock is in a free fall. If you’re a believer in the pot industry, this might be your best chance at capitalize on a hyper-growth opportunity.

| More on:
Financial technology concept.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

HEXO (TSX:HEXO)(NYSE:HEXO) stock is in a free fall. From April to September, shares fell by 50%. Then, on October 10, the stock dropped 25% in a single trading session. So far, the declines are continuing. Once a $3 billion company, HEXO is now worth just $900 million. Investors and analysts are fleeing the stock en masse.

What happened to this former market darling? If you have the courage, now might be your chance to capitalize on a high-growth stock with a rock-bottom valuation.

Cannabis blues

It’s not just HEXO stock that’s falling. Alternative Harvest ETF, one of the largest pot ETFs, is down 50% since the year began. The vast majority of cannabis stocks are deep in the red. From independent growers like Green Organic Dutchman Holdings to companies with multi-billion-dollar partners like Cronos Group, the entire industry is in pain.

This month, HEXO added a significant amount of additional fear to the downturn. On October 10, the company noted that quarterly results will come in well below expectations. For instance, quarterly revenue should be around $15 million versus previous guidance of roughly $30 million. Management is blaming “lower-than-expected product sell through.”

The most concerning news was that management will be withdrawing its 2020 guidance, which had predicted sales reaching $400 million. The market was already skeptical given analysts were forecasting 2020 revenue of only $280 million, but the formal withdrawal still spooked investors. While early advocates were big believers in the pot market, it seems as if true growth may take several years to transpire.

How to invest

If you’ve been invested in pot stocks like HEXO, you’re likely hurting right now. But if you’re a believer in the long-term story, it’s hard not to consider shares a buy. This year, HEXO should post sales of around $40 million. Next year, even using lowered estimates, sales should at least quadruple. By 2021, analysts expect the company to reach $400 million in sales. That’s a year later than expected, but the growth should still occur.

Looking back, the market should have expected a bumpier ride. While Canada led the way with full recreational legalization, federal legalization in the U.S. — a market that will likely be at least 1,000% bigger — could still be a decade away. To be sure, pot demand will continue to grow. Most analysts expect the market size to exceed $80 billion by 2030, but the road to getting there won’t be linear.

If you want to invest in the cannabis roller coaster, choose high-quality companies and double down when prices get cheap. While it’s not a perfect story, HEXO is still moving forward with its plan to become the pot market’s first platform company. By next year, any external business will be able to use HEXO to create safe, effective, and regulatory-compliant cannabis products. It’s already forged an agreement with Molson Coors Canada, and management expects many other Fortune 500 companies to join.

Emerging industries like pot will remain volatile. Know which companies you believe in and have the courage to buy when others are fearful. For HEXO stock, that time appears to be now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of Molson Coors Brewing. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »